126 related articles for article (PubMed ID: 21458518)
1. Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.
Haritova A; Urumova V; Lutckanov M; Petrov V; Lashev L
Food Chem Toxicol; 2011 Jul; 49(7):1530-6. PubMed ID: 21458518
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
Soliman GA
Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
Mengozzi G; Intorre L; Bertini S; Soldani G
Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in chicken based on retrospective data, incorporating first-pass metabolism.
Guo QJ; Huang LL; Fang K; Wang YL; Chen DM; Tao YF; Dai MH; Liu ZL; Peng DP; Yuan ZH
J Vet Pharmacol Ther; 2010 Feb; 33(1):84-94. PubMed ID: 20444030
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and residues of enrofloxacin in chickens.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Bringas P; Martínez MA; Fernàndez-Cruz ML; Fernández MC; Fernández R
Am J Vet Res; 1995 Apr; 56(4):501-6. PubMed ID: 7785830
[TBL] [Abstract][Full Text] [Related]
8. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
[TBL] [Abstract][Full Text] [Related]
10. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
Li Q; Bi X; Diao Y; Deng X
Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
[TBL] [Abstract][Full Text] [Related]
11. Effects of aflatoxin B1 on tissue residues of enrofloxacin and its metabolite ciprofloxacin in broiler chickens.
Kalpana S; Aggarwal M; Srinivasa Rao G; Malik JK
Environ Toxicol Pharmacol; 2012 Mar; 33(2):121-6. PubMed ID: 22209724
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of enrofloxacin in chickens.
Abd el-Aziz MI; Aziz MA; Soliman FA; Afify NA
Br Poult Sci; 1997 May; 38(2):164-8. PubMed ID: 9158891
[TBL] [Abstract][Full Text] [Related]
14. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine.
Post LO; Farrell DE; Cope CV; Baker JD; Myers MJ
J Pharmacol Exp Ther; 2003 Feb; 304(2):889-95. PubMed ID: 12538847
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog.
Cester CC; Toutain PL
J Pharm Sci; 1997 Oct; 86(10):1148-55. PubMed ID: 9344173
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Meinen JB; McClure JT; Rosin E
Am J Vet Res; 1995 Sep; 56(9):1219-24. PubMed ID: 7486402
[TBL] [Abstract][Full Text] [Related]
18. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
19. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
Fu LX; Jiang ZG; Ding HZ; Liu YH
J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
